Treating all chronic hepatitis C genotype 1 patients that are in fibrosis stages F1F4 with boceprevir- (BOC) or telaprevir- (TVR) based triple therapy, is cost effective over a lifetime horizon, according to a study presented at the 49 th Annual Meeting of the European Association for the ...
doi:10.1001/jama.290.15.1994-aLETTERS to the editorHEPATITIS CPresents a letter to the editor discussing the cost-effectiveness of treatment for chronic hepatitis C infection.JAMA: Journal of the American Medical AssociationSalomon, Joshua A.Goldie, Sue J....
As you're probably aware, this has been a very interesting few weeks for hepatitis C treatment. We had the Liver Congress in Europe (the European Association for the Study of the Liver, or EASL), where we saw many exciting and promising treatments -- all interferon-free and really raising...
Treating all U.S. prisoners who have hepatitis C with the standard therapy of pegylated-interferon and ribavirin would be cost-effective, says a new study in the November issue of Hepatology, a journal published by John Wiley & Sons on behalf of the Amer
Cost-effectiveness of Treatment for Chronic Hepatitis C Infection—Reply Presents a letter to the editor discussing the cost-effectiveness of treatment for chronic hepatitis C infection. Salomon, Joshua A.,Goldie, Sue J. - JAMA: Journal of the American Medical Association 被引量: 0发表: 2003年 ...
A study led by Boston Medical Center (BMC) researchers demonstrates that while new therapies to treat Hepatitis C Virus (HCV) are highly effective, they are cost-effective and provide the greatest value in specific groups of HCV-infected patients. The findings of the study, led by Benjamin P....
The treatment of chronic hepatitis C has advanced considerably during the past 15 years. The aim of this study was to evaluate the impact of different key developments from a health-economic perspective. Costs and health-related quality-of-life data from a follow-up of Swedish patients treated ...
Hepatitis C virusPregnant womenHCV screeningDirect-acting antiviralsBackground The prevalence of diagnosed chronic hepatitis C virus (HCV) infection among pregnant women in the Netherlands is 0.26%, yet many cases remain undiagnosed. HCV screening and treatment of pregnant HCV carriers could reduce the...
Cost-effectiveness analysis of a multidisciplinary support program in hepatitis C treatmentCost-effectiveness analysis of a multidisciplinary support program in hepatitis C treatmentGarciaRetortillo, MCirera, IGimenez, M DMarquez, CCanete, NCarrion, J ACastellvi...
Cost-effectiveness of Treatment for Chronic Hepatitis C Infection in an Evolving Patient Population OBJECTIVE: To examine the clinical benefits and cost-effectiveness of newer treatments for chronic hepatitis C infection in a population of asymptomatic, HCV... D Bernstein - 《Jama》 被引量: 539发表...